A exploração visual dos dutos biliares é de relevante interesse clínico, pois fornece informação relacionada com a Atresia Biliar (AB). A AB é uma doença cujas causas ainda permanecem desconhecidas e que eventualmente leva a um transplante de fígado ou, nos casos mais avançados da doença, leva a óbito do paciente. A única evidência física conhecida até agora da existencia de AB é a obstrução das vias biliares. No entanto, o estudo desta doença tem sido limitado pela incapacidade de analisar o duto biliar de pacientes em estágios precoces da doença e muito pouco se sabe sobre a estrutura interna do duto biliar. Nos últimos anos, a microscopia confocal, uma técnica que permite a obtenção de conjuntos de dados 3D de amostras biológicas, tem sido utilizada em experiências médicas para estudar a estrutura interna e anatômica dos dutos biliares. Neste trabalho, é objetivo apoiar o estudo dessas estruturas através da visualização volumétrica de imagens dos dutos biliares. É proposto um pipeline de fluxo de dados capaz de processar e "renderizar"conjuntos de dados de imagens confocais utilizando o VTK (do inglês The Visualization ToolKit). O pipeline foi construído em duas etapas principais e consecutivas. Uma primeira etapa tem o objetivo de remoção de ruído e realce das estruturas relevantes por meio de filtragem no domínio da freqüência e difusão anisotrópica. O conjunto de dados assim pré-processado é usado com técnicas diretas de visualização de volumes baseadas em funções de transferência para exibir as estruturas dos dutos biliares. Os resultados mostram que a visualização volumétrica em conjunto com um pré-processamento adequado das imagens confocais permite evidenciar as regiões de interesse nos dutos biliares e melhora detalhes que são dificilmente visualizados nos dados originais. / The visual exploration of bile ducts in the liver is of relevant clinical interest, as it provides information related to the Biliary Atresia, a disease of unknown origin, which eventually leads to a liver transplant or ultimately to death. The only physical known evidence of biliary atresia is the obstruction of the bile ducts. However, the study of this disease has been limited by the inability to observe the bile duct in patients at early stages of the disease. Moreover, very little is known about the internal structure of the bile duct. In recent years, confocal microscopy, a technique that allows to obtain 3D image datasets from biological samples, has been used in medical experiments for studying the anatomical internal structure of bile ducts. We are interested in supporting the study of these structures through volumetric visualization of bile ducts images. In this work, we propose a data flow pipeline capable of processing and rendering datasets of confocal images using The Visualization ToolKit - VTK. The pipeline was built as two consecutive stages. We propose a first stage for denoising and enhancing the relevant structures of sample based on filtering in the frequency domain and anisotropic diffusion. We use the dataset preprocessed in this way for applying a direct volume rendering technique in a second stage based on transfer functions to visualize the bile duct structures. Our results have shown that volumetric visualization together with an adequate pre-processing of the confocal images allow experts to visualize the regions of interest in the bile ducts, improving details that are hardly visualized in the original data.

Submitted by Renata Lopes (renatasil82@gmail.com) on 2016-06-16T19:51:10Z No. of bitstreams: 1 paulohenriquediasdecarvalho.pdf: 3125617 bytes, checksum: 3e951b5c5e73d3862e1ed9b6e9e28451 (MD5) / Approved for entry into archive by Adriana Oliveira (adriana.oliveira@ufjf.edu.br) on 2016-07-13T14:26:36Z (GMT) No. of bitstreams: 1 paulohenriquediasdecarvalho.pdf: 3125617 bytes, checksum: 3e951b5c5e73d3862e1ed9b6e9e28451 (MD5) / Made available in DSpace on 2016-07-13T14:26:36Z (GMT). No. of bitstreams: 1 paulohenriquediasdecarvalho.pdf: 3125617 bytes, checksum: 3e951b5c5e73d3862e1ed9b6e9e28451 (MD5) Previous issue date: 2013-07-26 / CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico / FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais / A descoberta de protótipos naturais associada às metodologias de isolamento e identificação química de constituintes a partir de novas fontes botânicas, bem como da avaliação das atividades farmacológicas e toxicológicas dessas moléculas demonstram grandes perspectivas para o desenvolvimento racional de novos fármacos. Tendo em vista a alta incidência de doenças do fígado, no Brasil e no mundo, e que existem poucos medicamentos eficazes e capazes de reverter ou reduzir a progressão destas, o isolamento e a identificação de substâncias com potencial hepatoprotetor é, hoje, uma área promissora na busca de novas substâncias bioativas. Tradicionalmente, as raízes de Glycyrrhiza sp., conhecidas como licorice, são usadas na medicina alternativa com inúmeras finalidades, dentre elas hepatoprotetora. Entretanto, até o momento, não existem relatos desta atividade vinculada à licochalcona A, uma das substâncias majoritárias nas raízes de Glycyrrhiza inflata. No presente trabalho avaliaram-se as atividades da licochalcona A em ensaios de viabilidade celular das linhagens de fibroblásto (NIH/3T3) e carcinoma hepatocelular humano (HepG-2), adesão celular de HepG-2 e em modelo de lesão hepática induzida por ligação do ducto biliar (BDL) em ratos Wistar. Além disso, desenvolveu-se uma metodologia para determinação da licochalcona A em CLAE-UV, utilizando coluna C18, fase móvel em gradiente de água acidificada (0,1% H3PO4) e metanol (50:50 – 20:80 v/v), fluxo de 1,1 mL/min e comprimento de onda para detecção em 372 nm. A licochalcona A isolada a partir do extrato seco das raízes de G. inflata foi identificada por RMN 1H e 13C. O isolamento apresentou-se satisfatório, bem como a metodologia proposta para quantificação desta substância por CLAE-UV, que apresentou excelente linearidade, precisão e exatidão. Nos experimentos in vitro, a licochalcona A não demonstrou redução significativa na viabilidade das células da linhagem HepG-2 (IC50 > 200 μM) e da NIH/3T3 (IC50 > 100 μM), bem como no experimento de adesão das células HepG-2 (IC50 > 200 μM) (p>0,05). Estes dados corroboram com aqueles encontrados no experimento in vivo, no qual a licochalcona A (50 mg/Kg) também não apresentou toxicidade ao fígado, já que os resultados encontrados não foram significativamente diferentes aos do grupo controle (p>0,05). Contudo, ela também não demonstrou capacidade de promover ou reduzir os danos hepáticos causado pelo BDL, no tempo de tratamento do estudo realizado (48 h). / The natural prototypes discovery associated with methods of chemical constituents isolation and identification from new botanical sources, as well as the evaluation of pharmacological and toxicological activities of these molecules show great prospects for the new drugs rational development. In view of the high incidence of liver disease in Brazil and the world, and there are few effective drugs and able to reverse or slow the progression of these disease, the substances isolation and identification with potential hepatoprotective today is a promising area in search for new bioactive substances. Traditionally, the roots of Glycyrrhiza sp., known as licorice, are used in alternative medicine with numerous purposes, among them hepatoprotective. However, to date, there are no reports of this activity linked to licochalcona A, one majority of the substances in the roots of Glycyrrhiza inflata. In the present study evaluated the activities of licochalcone A in cell viability assays of strains fibroblast (NIH/3T3) and human hepatocellular carcinoma (HepG-2), cell adhesion HepG-2 and model of liver injury induced by bile duct ligation (BDL) in Wistar rats. In addition, we developed a methodology for determining the licochalcone A quantitative HPLC-UV, using C18 column and a mobile phase gradient of acidified water (0.1% H3PO4) and methanol (50:50 - 20:80 v/v), flow rate of 1.1 mL/min and detection wavelength at 372 nm. The licochalcone A isolated from the dried extract of the roots of G. inflata was identified by 1H and 13C NMR. The isolation had to be satisfactory, as well as the proposed methodology for quantification of this substance by HPLC-UV, which showed excellent linearity, reproducibility and accuracy. In in vitro experiments, licochalcone A showed no significant reduction in the viability of the cell line HepG-2 (IC50 > 200 μM) and NIH/3T3 (IC50 > 100 μM), as well as in cell adhesion HepG-2 experiments (IC50 > 200 μM) (p> 0.05). These data corroborate those found in the in vivo experiment, in which the licochalcone A (50 mg/kg) also showed no toxicity to the liver, since the results were not significantly different to the control group (p>0.05). Nevertheless, it has not shown the ability to promote or reduce liver damage caused by BDL, at the treatment time of the study (48 h).

As células derivadas de fígado embrionário tanto de animais quanto de humanos tem sido cada vez mais estudas devido ao seu potencial antiinflamatório, imunomodulador e regenerativo, demonstrado as mesmas bipotencial de diferenciação em hepatócitos e colangiocitos. Na presente pesquisa utilizou-se células derivadas de fígados embrionários de ratos com 14,5 dias de gestação. As células apresentaram marcadores de células progenitoras hepáticas, bem como marcadores de células hepáticas e biliares diferenciadas confirmando, seu bipotencial. A terapia celular utilizando as células supracitadas, reduziu significativamente a progressão da fibrose hepática, diminuindo a inflamação e ainda estimulando a regeneração hepática de ratos submetidos à cirrose por ligadura do ducto biliar. As análises realizadas mediante avaliação quantitativa pela técnica de morfometria, demonstraram redução da deposição de fibras de colágeno, bem como menor proliferação de ductos biliares nos animais tratados. Os resultados foram ainda complementados por analise semiquantitativa, a qual avaliou a intensidade da necroinflamação dos tecidos hepáticos analisados, apontando menor escore de inflamação dos animais tratados. As células poderão ter efeito benéfico para o tratamento de doenças hepáticas crônicas, que estimulam a formação de fibrose. A cirrose é o estágio final comum à doenças hepáticas crônicas por causadas por fatores de diversas etiologias. Esta ocupa a decima quarta causa mundial de mortalidade em humanos, sendo que o único tratamento definitivo atualmente é transplante do órgão. Entretanto o número de transplantes está longe de suprir a demanda atual, visto que há um déficit de doadores do órgão. Terapias que possam oferecer uma alternativa de tratamento confiável, segura e acessível são bastante oportunas. Nossos resultados sugerem que as células utilizadas neste trabalho podem modular a fibrogênese, e consequentemente retardar o estabelecimento da cirrose em doenças hepáticas crônicas. / Studies on human and animal embryonic liver stem cells have been growing due to its anti-inflammatory, immunomodulatory and regenerative potential. These cells show also a bipotential do differentiate into hepatocytes and cholangiocytes. In the present study, it was used rodent embryonic liver with 14.5 of gestation. The cells presented hepatic progenitor, as well adult hepatic and biliary cells markers, confirming their bipotential. Previous studies with these cells in therapy decreased hepatic fibrosis progression in rat models submitted to cirrhosis by biliary duct ligation. Quantitative analysis was performed by morphometry showed decreased collagen fibers deposition and lower proliferation of biliary ducts in treated animals. Results were complemented with semiquantitative analysis with evaluation of necroinflammation of the analyzed hepatic tissues, in which a decreased inflammation score was observed. Cirrhosis is a common final stage for chronic hepatic diseases caused by different factors in several etiologies. It occupies the 14th world cause of mortality in human. However, the number of liver transplants is insufficient for current demand, caused by deficit in organs donors. Therapies that could offer an alternative for a reliable, safe and accessible treatment is opportune. Our results suggest that cells used in this study can modulate fibrogenesis and consequently delay the establishment of cirrhosis in chronic liver diseases.

A ema (Rhea americana americana) é uma ave que pertence ao grupo das Ratitas, ordem Rheiforme e a família Rheidae. Neste trabalho foram analisadas as características morfológicas, macroscópicas e microscópicas, dos órgãos do aparelho reprodutor masculino (testículos, epidídimos, ductos deferentes e falo) e a cloaca em 23 emas, quatro filhotes com duas semanas, sete jovens (de três a oito meses) e doze adultas (três anos), provenientes do abatedouro da Cooperativa Emas do Brasil, RS e do CEMAS, Mossoró, RN. Fragmentos de cada órgão foram fixados por imersão em formoldeído 10%, tampão fosfato pH 7,4, 0,1M ou em solução de Karnovsky (paraformoldeído 4% e glutaraldeído 2,5%, tampão fosfato pH 7,4, 0,1M) e processados na rotina para microscopia de luz e eletrônica de varredura, respectivamente. Os testículos da ema possuem formato alongado e localizam-se na cavidade celomática, na região intra-abdominal dorsal, com comprimento e largura médias de 7,6 ± 1,2 cm e 2,6 ± 0,7 cm nos adultos; 4,5 ± 1,5 cm e 0,9 ± 0,4 cm nos jovens; e 0,8 ± 0,3 cm, e 0,2 ± 0,1 cm nos filhotes. O testículo está envolto pela túnica albugínea e seu parênquima possui túbulos seminíferos, compostos por epitélio espermatogênico e por células de sustentação, e pelo tecido intersticial, com as células endócrinas intersticiais, tecido conjuntivo frouxo e vasos. Nos adultos observaram-se todas as células da linhagem espermatogênica, enquanto nos jovens com 3 meses os testículos apresentaram túbulos seminíferos com luz reduzidas, espermatogônia e células de sustentação indiferenciadas. O epidídimo apresentou-se alongado e fusiforme junto a margem medial do testículo. Os ductos eferentes possuem um epitélio pseudoestratificado colunar ciliado baixo, enquanto no ducto epididimário o epitélio é alto. O ducto deferentes apresentou trajeto sinuoso nos adultos, retilíneo nos jovens, convoluto na sua porção média, diminuindo seu formato sigmóide em sua porção caudal, próximo à cloaca. O epitélio é pseudoestratificado reveste a luz irregular nos adultos, e circular nos jovens, mantendo proximidade com o ureter. A cloaca dividiu-se em três segmentos: o coprodeu, o urodeo e o proctodeo. No urodeu os ductos deferentes desembocaram em papilas na parede ventro-lateral, próximo a inserção do falo fibroso. O falo é um órgão fibroso linfático, localizado na parede ventral, no assoalho da cloaca, e apresentou duas porções: uma rígida bifurcada e contorcida, e outra simples espiralada e flexível, a qual normalmente esteve invertida. De forma geral os órgãos reprodutores das emas compartilharam da morfologia de outras aves, principalmente aquelas descritas para os avestruzes. / The ema (Rhea american american) is a bird that belongs to the group of the Ratitas, order Rheiforme and family Rheidae. At this study were analyzed the morphological characteristics, macroscopic and microscopic, of the male genital organ (testes, epididymis, deferent ducts, and fhallus) and the cloaca in 23 emas, four chicken (two weeks old), young witer three to ten months old and twelve adult animals (three years old), originating from Cooperativa Emas do Brasil, RS and also from CEMAS, Mossoró, RN. Slices from each organ were fixed by immersion in phorformaldehyde 10%, or in Karnovsky solution (phorformaldehyde 10%, buffer phosphate pH 7.4, 0.1M and glutaraldehyde 2.5% buffer phosphate pH 7.4, 0.1M) and processed for light and scanning microscopy, respectively. The testis of rhea had elongated shape and were located inside coelomatic cavity, in dorsal region of abdominal cavity, with medium length and width of 7.6 ± 1.2 cm and 2.6 ± 0.7 cm at adult animals; 4.5 ± 1.5 cm and 0.9 ± 0.4 cm at young animals; and 0.8 ± 0.3 cm, and 0.2 ±0.1 cm at chicken. The testis were recovered by the tunica albuginea and its parenchyma had seminiferous tubules composed by spermatogenic epithelium and by sustentation cells, and also interstitial tissue, with interstitial endocrine cells, connective tissue and vessels. At the adult animals were observed all the cells from spermatogenic lineage, whilst at the youngs with 3 months the seminiferous tubules had a smale lumen with spermatogonia and undifferentiated sustentacular cells. The epididymis was elongated and fusiform closely to medial testis board. The efferents ductus were composed by a low ciliated pseudoestratified epithelium, while the epididimydis duct had a light epithelium. The deferent duct had sinuous stretch at adult animals, rectilineae at young animal, convolute at its medium portion, decreasing its sigmoid shape at caudal portion, next to cloaca. The epithelium was pseudostratified ciliated, irregular lumen at adult animal, and circular at young animal, closely with urether. The cloaca was divided into three segments: coprodeum, urodeum and proctodeum. At urodeum the deferent ducts discharged into papillas at the ventral side wall, next to fibrous phallus`s insertion. The phallus was a lymphatic fibrous organ, located at ventral wall, at the cloaca floor, and was composed by two portions: one rigid forked and twisted, and another simple spiraled and flexible, which normally was inverted. In a general way the Rhea genital organs shared the morphology from others birds, mainly those described to the ostrich.

Abstract The embryonic urogenital system (UGS) generates the metanephric kidney, gonad and the adrenal gland. It is well known that the development of the UGS is regulated by sequential and reciprocal epithelial and mesenchymal tissue interactions but the secreted mediators involved are still poorly known. The action of such inductive signals is typically regulated by specific antagonists. The Sprouty (Spry) proteins compose one family of cytoplasmic regulators that typically repress the function of the receptor tyrosine kinase (RTK) signal transduction pathways. The DAN/Cerberus (Cer) family that encodes secreted proteins bind and antagonize the Bmp, Wnt and Nodal signals. In this study the roles of Spry and Cer1 was addressed during mouse UGS development by targeted expression of SPROUTY2 (SPRY2) and Cer1 in the ureteric bud and Wolffian duct under the Pax2 promoter. Changes induced in the UGS assembly process were analyzed in detail to reveal the normal developmental roles of these proteins. SPRY2 expression led to either complete lack of the kidney, reduction in the kidney size or formation of unilateral kidney with reduced size. The SPRY2 mediated reduction in kidney size was accompanied by inhibition of expression of genes that are known to regulate kidney development. The results indicated that the Spry may take part in kidney development by coordinating the reciprocal cell signaling between the ureteric bud, the mesenchymal cells and stromal cells. In addition to the kidney, the gain of SPRY2 function revealed an important role in the control of male gonadogenesis. SPRY2 over expression in the Wolffian duct malformed the Wolffian duct derivatives, diminished the number of seminiferous tubules and the amount of the interstitial tissue associated with reduced mesonephric cell migration to the testis. Exogenous FGF9 rescued mesonephric cell migration inhibited by SPRY2. It was concluded that Spry protein contribute to male sexual organogenesis by antagonizing Fgf9 signaling. When the Cer1 gene was over expressed in the ureteric bud this lead unexpectedly to increased kidney size. The Cer1 mediated promotion of kidney size was demonstrated to involve enhanced ureteric bud morphogenesis. At the molecular level Cer1 protein function lead to inhibition of Bmp4 gene expression and concurrent upregulation of Gdnf and Wnt11 expression. Notably, excess BMP4 reduced the Cer1 stimulated ureteric bud branching and downregulated normally expression of Gdnf and Wnt11 in the embryonic kidney. Based on the presented data it is proposed that the establishment of mammalian organ size is under the control of both systemic and the intrinsic factors. Together the work demonstrates significant roles for the proteins that typically inhibit growth factor signaling or signal transduction. Hence organogenesis is controlled by coordination between positive and negative growth factor regulator signals.

Cyclooxygenases (COXs) and their main renal product, prostaglandin E2 (PGE2), regulate many physiological renal functions and are involved in the pathogenesis of diabetic kidney disease. The PGE2 receptor EP3 has been repeatedly shown to be upregulated during diabetes. Physiologically, EP3 is best recognized to act as a diuretic by antagonizing arginine-vasopressin (AVP)-mediated water reabsorption. Incidentally, the first renal manifestation of diabetes is polyuria, which may trigger a cascade of events leading to DN. We hypothesize that EP3 contributes to polyuria and kidney dysfunction during diabetes. We injected EP3-/- mice with streptozotocin (STZ) and evaluated their renal function 12-weeks post injection. EP3-/- STZ mice exhibit attenuated polyuria while exhibiting increased urine osmolality suggesting enhanced water reabsorption. Western blots reveal that EP3-/- STZ mice have increased expression of aquaporin-1 and aquaporin-2 as well as reduced urinary AVP excretion compared to STZ mice. However, salt transporters were equivalently increased in STZ and EP3-/- STZ mice. In vitro microperfusion shows that EP3 completely abrogates AVP-mediated water reabsorption in STZ cortical collecting ducts. Furthermore, EP3-/- STZ mice showed blunted renal COX-2 expression as well as reduced renal hypertrophy, glomerular hyperfiltration, and albuminuria. Taken together, the data suggests that EP3 contributes to polyuria during diabetes by inhibiting expression of aquaporins. Additionally, EP3 seems to contribute to renal COX-2 induction during diabetes. The lack of an increase in renal COX-2 protein levels in EP3-/- STZ mice may be protective by preventing further renal damage.

Prostaglandin E2 (PGE2), a metabolite of arachidonic acid, plays a role in water and sodium reabsorption in the collecting duct of the kidney. The collecting duct is responsible for the fine tuning of water and electrolytes. Only a small fraction of the filtered water and sodium is reabsorbed in the collecting duct, a fraction crucial to the regulation of water and electrolyte balance. This current study addresses the role of EP1, one of four PGE2 receptors, in the collecting duct. It is well documented that PGE2 inhibits sodium and water reabsorption in the collecting duct, however the exact mechanism is still debated. To determine whether the EP1 receptor mitigates AngII renal effects, an in vivo study was performed with EP1-/- mice. Global EP1-/- knockout mice were crossed with a renin overexpressing mouse line (herein denoted as “Ren”) and subjected to a high salt (HS) and low salt (LS) diet. Ren mice displayed an 11mmHg increase in systolic blood pressure (BP) on a HS diet and a decrease in BP of 14mmHg on a LS diet compared to the normal salt (NS) diet. Ren EP1-/- mice did not display a significant increase or decrease in BP on a HS or LS diet. On a LS diet, Ren EP1-/- displayed a drop in urine osmolarity (1641 mOsm/ kgH2O) vs. wild type (WT) mice (2107 mOsm/ kgH2O), consistent with increased sodium reabsorption. Narrowing in on the collecting duct, Ren EP1-/- mice had enhanced αENaC levels compared to Ren mice. In ex vivo microperfusion experiments, EP1-/- tubules show no response to PGE2 in the presence of AVP, whereas PGE2 inhibits AVP induced water reabsorption in WT mice. An increase in αENaC membrane accumulation due to EP1 gene ablation results in increased sodium reabsorption subsequently leading to a rise in BP. This contributes to the lack of salt sensitivity in EP1-/- mice. Overall, the EP1 receptor in the collecting duct represents a potential therapeutic target for the treatment of hypertension.

Nous avons récemment démontré un bénéfice de l’implantation d’un drain biliaire interne (IBS-Internal Biliary Stent) afin de réduire les complications biliaires en transplantation hépatique. Le drain IBS en silicone est utilisé en pratique clinique, son utilisation nécessite une procédure d’ablation endoscopique, intervention qui n’est pas dénuée de complications. Afin d’éviter cela, et pour réduire les complications biliaires après transplantation hépatique, nous avons cherché à développer une prothèse biliaire interne résorbable (RIBS-Resorbable Internal Biliary Stent), fabriquée à partir d'un polymère dégradable radio-opaque. Pour être implantable, le RIBS doit répondre à un cahier des charges.Le premier objectif de ce travail était de synthétiser le matériau et le mettre en forme à partir d'un copolymère tribloc initialement sélectionné de PLA50-PEG-PLA50 avec un additif radio-opaque composé d’un copolymère de triiodobenzoate-poly(-caprolactone) (PCL-TIB). Le RIBS doit non seulement être toléré par l’organisme mais doit permettre de sécuriser l’anastomose biliaire et favoriser la régénération tissulaire biliaire pour ensuite être éliminée de l’organisme. Ce dispositif doit également répondre aux objectifs très strictes liés à l’implantation et au suivi en TH. Le second objectif était de caractériser le RIBS de PCL-TIB/PLA50-PEG-PLA50, en évaluant si les propriétés au cours de la dégradation in vitro et in vivo étaient conformes au cahier des charges. Une étude in vitro dans un environnement biliaire simulé et une étude in vivo chez le rat ont été réalisées. Nous avons observé les propriétés physico-chimiques, la visualisation radiologique, l'histologie et le comportement mécanique au cours de la dégradation. Enfin, le dernier objectif était d'évaluer l'implantabilité ex vivo dans les voies biliaires humaines, avec une étude du comportement mécanique des voies biliaires et des tests d'implantation sur des pièces anatomiques.Dans cette thèse, le comportement radiologique et mécanique du dispositif RIBS innovant a été évalué avec succès au cours la dégradation in vitro et in vivo, avec des propriétés qui répondaient aux exigences. Un prototype de RIBS a été implanté avec succès dans une pièce anatomique humaine. Ces travaux ont permis le développement d’un dispositif innovant, à savoir un IBS traçable et biodégradable utilisable pour réduire les complications biliaires en transplantation hépatique. / Benefit of implantation of an internal biliary stent (IBS) during liver transplantation to reduce biliary complications was recently demonstrated. Silicone IBS was used in practice, which require an endoscopic ablation procedure, a potentially morbid intervention for the patient. In order to avoid this, and to reduce biliary complications after liver transplantation we develop a resorbable internal biliary stent (RIBS), made from a degradable polymer visualizable by X-ray. To be usable and useful, RIBS must comply specifications, which are developed in this thesis.The first aim of the present work, was to synthetize a material based on a selected PLA50-PEG-PLA50 triblock copolymer with a triiodobenzoate-poly(-caprolactone) radiopaque copolymer (PCL-TIB) as additive and design a RIBS. It must be biocompatible, should secure the biliary anastomosis and enable biliary regeneration. This device will also have to meet the very strict objectives related to implementation and monitoring in liver transplantation. The second objective was to characterize the PCL-TIB/PLA50-PEG-PLA50 RIBS, by evaluating whether properties during in vitro and in vivo degradation complied the specifications. An in vitro study in a simulated biliary environment and an in vivo rats implantation study was realized. We observed physico-chemical properties, radiological visualization, histology, and mechanical behavior during degradation. The last aim was to evaluate ex vivo implantability in human bile ducts, with the study of the bile duct mechanical behavior, and implantation tests on anatomic specimens.In this thesis, radiological and mechanical behaviour of novel radiopaque and resorbable IBS was successfully evaluated during in vitro and in vivo degradation with properties that meet requirements. A RIBS prototype device was successfully implanted in human anatomic specimen. The results obtained will allow the development of a novel class of trackable and degradable IBS to reduce biliary complications after liver transplantation.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第22879号 / 医博第4673号 / 新制||医||1047(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 川口 義弥, 教授 柳田 素子, 教授 小川 修 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

The mein objective of this diploma thesis is to optimize the oil cooler of the VUT 100 aircraft, so that it complies with the CS-23 regulation and requirements of the engine producer. This is fulfilled by using of suitable oil cooler and by optimization of the air duct. Computational Fluid Dynamics approach – namely Ansys Fluent software package is used for it.